Citadel Advisors »

C4 Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $786k 138k 5.70
2024-06-30 $2.5M 532k 4.62
2024-03-31 $4.4M 543k 8.17
2023-12-31 $2.0M 353k 5.65
2023-09-30 $778k 418k 1.86
2023-06-30 $1.9M 703k 2.75
2023-03-31 $1.8M 559k 3.14
2022-12-31 $2.3M 393k 5.90
2022-06-30 $296k 39k 7.55
2022-03-31 $3.5M 143k 24.26
2021-12-31 $5.8M 181k 32.20
2021-09-30 $2.1M 47k 44.68
2021-06-30 $5.0M 133k 37.83
2021-03-31 $749k 20k 37.00
2020-12-31 $3.4M 104k 33.13